What type of study is this?

This is a In Vitro Study study (also classified as: Animal Study).

In Vivo Tumor Growth Control by General Control Nonderepressible 2 Targeting Agents Results from Kinase Activation

View Full Paper

Ask AI

Bookmark

Authors

Experimental analysis reveals GCN2 activation reduces tumor growth in vivo, suggesting new treatment avenues.

Activation of the gcn2 pathway leads to decreased tumor growth and cell viability, while inhibition does not.
In vitro experiments found that activating doses of gcn2 agents induce cleaved caspase 3, a marker of apoptosis.
The integrated stress response pathway plays a crucial role in tumor growth modulation by gcn2-targeting agents.
These findings highlight the potential for developing gcn2 targeting compounds in cancer therapy.

Tameire et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Experimental analysis reveals GCN2 activation reduces tumor growth in vivo, suggesting new treatment avenues.

Activation of the gcn2 pathway leads to decreased tumor growth and cell viability, while inhibition does not.
In vitro experiments found that activating doses of gcn2 agents induce cleaved caspase 3, a marker of apoptosis.
The integrated stress response pathway plays a crucial role in tumor growth modulation by gcn2-targeting agents.
These findings highlight the potential for developing gcn2 targeting compounds in cancer therapy.

Tameire et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark